Galectin Therapeutics Inc. – Credit Agreements

NASDAQ: GALT
Share price (6/26/26): $4.99
Market cap (6/26/26): $329 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

from 8-K 16 pages December 2025 Supplemental Line of Credit Letter Agreement

from 8-K 15 pages July 2025 Supplemental Line of Credit Letter Agreement

from 10-K 16 pages March 2025 Supplemental Line of Credit Letter Agreement

from 10-Q 15 pages November 2024 Supplemental Line of Credit Letter Agreement

from 10-K 4 pages Supplemental Line of Credit Letter Agreement

from 8-K 18 pages Line of Credit Letter Agreement

from 8-K 9 pages Loan Agreement

from 8-K 3 pages Second Amendment to Line of Credit Letter Agreement

from 8-K/A 4 pages First Amendment to Line of Credit Letter Agreement

from 8-K 18 pages Line of Credit Letter Agreement